{"text_format":"3","workbook":"xls","n_sheets":4,"sheets":["Epitopes Detailed","Protein Summary","Epitopes Topology","Scores"],"not_rendered":{"external_links":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Epitopes Detailed","index":0,"n_rows":4,"n_cols":24,"rows_kept":4,"flags":["formulas_cached_only"]}
["N","Id","Epitope","Start","End","N-Glyc","N-Glyc-Count","N-Glyc-Motifs","Length","MW(kDa)","I.P","Hydropathy","All Matches Cover","Avg Cover","BepiPred2","Emini","Parker","Chou Fosman","Karplus Schulz","Kolaskar","test_proteom_count","test_proteom_acc","test_proteom_count","test_proteom_id"]
[1,"4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation","PETQSSHSAW",73,83,"N",0,"-",10,1.13,5.25,-1.4,0.9,0.98,0.65,2.57,4.19,1.13,1.04,0.99,1,"4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",1,"4WFF_B(100.00,100.00)"]
[2,"4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation","AIFLKWHVPPELVR",149,163,"N",0,"-",14,1.71,8.8,0.42,0.07,0.6,0.64,0.82,-1.83,0.83,0.96,1.1,2,"4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation,4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",2,"4WFF_B(100.00,100.00),4WFF_A(100.00,100.00)"]
[3,"4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation","LKWHVPPELVRVLSA",150,165,"N",0,"-",15,1.74,8.75,0.39,0.07,0.59,0.63,0.81,-1.7,0.84,0.96,1.11,2,"4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation,4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",2,"4WFF_B(100.00,100.00),4WFF_A(100.00,100.00)"]

{"sheet":"Protein Summary","index":1,"n_rows":7,"n_cols":3,"rows_kept":7,"flags":["formulas_cached_only"]}
["Id","Epitopes","N-Glyc"]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",0,0]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",0,0]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",1,0]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",2,0]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",0,0]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",0,0]

{"sheet":"Epitopes Topology","index":2,"n_rows":28,"n_cols":17,"rows_kept":28,"flags":["formulas_cached_only"]}
["N","Id","         Method","Threshold","Avg Score","Cover","Epitope","Start","End","N-Glyc","N-Glyc-Count","N-Glyc-Motifs","Length","kDa","I.P","Avg Hydropathy","Avg Cover"]
[1,"4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation","   BepiPred-2.0",0.6,0.65,"-","PETQSSHSAW",73,83,"N",0,"-",10,1.13,5.25,-1.4,0.98]
["","","          Emini",0.8,2.57,0.9,"EEEEEEEEE.         "]
["","","         Parker",0.8,4.19,1,"EEEEEEEEEE         "]
["","","    Chou Fosman",0.8,1.13,1,"EEEEEEEEEE         "]
["",""," Karplus Schulz",0.8,1.04,1,"EEEEEEEEEE         "]
["","","       Kolaskar",0.8,0.99,1,"EEEEEEEEEE         "]
["","","    All matches","-","-",0.9,"EEEEEEEEE.         "]
["","","         N-Glyc","-","-","-","..........         "]
["","","     Hydropathy","-",-1.4,"-","--------+-         "]
[2,"4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation","   BepiPred-2.0",0.6,0.64,"-","AIFLKWHVPPELVR",149,163,"N",0,"-",14,1.71,8.8,0.42,0.6]
["","","          Emini",0.8,0.82,0.43,".....EEEE.EE..         "]
["","","         Parker",0.8,-1.83,0.07,".......E......         "]
["","","    Chou Fosman",0.8,0.83,0.5,".....EEEEEEE..         "]
["",""," Karplus Schulz",0.8,0.96,1,"EEEEEEEEEEEEEE         "]
["","","       Kolaskar",0.8,1.1,1,"EEEEEEEEEEEEEE         "]
["","","    All matches","-","-",0.07,".......E......         "]
["","","         N-Glyc","-","-","-","..............         "]
["","","     Hydropathy","-",0.42,"-","++++---+---++-         "]
[3,"4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation","   BepiPred-2.0",0.6,0.63,"-","LKWHVPPELVRVLSA",150,165,"N",0,"-",15,1.74,8.75,0.39,0.59]
["","","          Emini",0.8,0.81,0.4,"..EEEE.EE......         "]
["","","         Parker",0.8,-1.7,0.07,"....E..........         "]
["","","    Chou Fosman",0.8,0.84,0.47,"..EEEEEEE......         "]
["",""," Karplus Schulz",0.8,0.96,1,"EEEEEEEEEEEEEEE         "]
["","","       Kolaskar",0.8,1.11,1,"EEEEEEEEEEEEEEE         "]
["","","    All matches","-","-",0.07,"....E..........         "]
["","","         N-Glyc","-","-","-","...............         "]
["","","     Hydropathy","-",0.39,"-","+---+---++-++-+         "]

{"sheet":"Scores","index":3,"n_rows":1141,"n_cols":12,"rows_kept":1141,"flags":["formulas_cached_only"]}
["Id","Position","Residue","Bepipred2","Emini","Parker","Chou Fosman","Karplus Schulz","Kolaskar","MW","IP","Hydropathy"]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",1,"V",0.23,0,0,0,0,0,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",2,"R",0.27,0,0,0,0,0,174.2,9.75,-4.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",3,"S",0.31,0.23,0,0,0,0,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",4,"L",0.33,0.45,1.63,1.03,0.98,1.09,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",5,"N",0.39,0.19,0.84,1.04,0.97,1.07,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",6,"C",0.4,0.28,0.84,1.04,0.96,1.07,121.15,5.52,2.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",7,"T",0.41,0.56,1.34,1.04,0.96,1.05,119.12,5.19,-0.7]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",8,"L",0.42,0.47,3.59,1.16,0.99,1.01,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",9,"R",0.44,1.5,3.44,1.08,1.03,1.05,174.2,9.75,-4.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",10,"D",0.45,1.8,4.1,1.05,1.07,0.99,133.1,3.8,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",11,"S",0.46,4.37,4.17,1.06,1.11,0.99,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",12,"Q",0.45,2.99,6.41,1.18,1.12,0.96,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",13,"Q",0.45,1.48,4.5,1.13,1.12,1.01,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",14,"K",0.43,0.82,2.54,0.99,1.08,1.09,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",15,"S",0.43,0.47,1.01,0.87,1.03,1.06,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",16,"L",0.43,0.36,1.09,0.93,0.99,1.06,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",17,"V",0.42,0.18,1.04,1.02,0.97,1.04,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",18,"M",0.42,0.21,0.53,1.09,0.98,1.06,149.21,5.28,1.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",19,"S",0.41,0.39,-0.67,1.05,1.01,1.08,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",20,"G",0.39,0.92,1.76,1.07,1.03,1.02,75.07,5.52,-0.4]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",21,"P",0.41,0.76,0.97,1.08,1.03,1.01,115.13,5.96,-1.6]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",22,"Y",0.42,1.14,2.39,1.14,1.01,1.02,181.19,5.52,-1.3]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",23,"E",0.43,1.16,1.76,1.03,0.99,1.03,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",24,"L",0.43,0.62,-0.37,0.89,0.98,1.08,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",25,"K",0.43,0.54,-0.37,0.81,0.97,1.09,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",26,"A",0.44,0.26,-1.41,0.73,0.96,1.1,89.09,5.57,1.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",27,"L",0.46,0.54,-1.67,0.77,0.95,1.12,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",28,"H",0.48,0.27,0.46,0.91,0.96,1.07,155.16,6.74,-3.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",29,"L",0.52,0.46,0.5,0.9,0.99,1.08,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",30,"Q",0.54,0.92,1.63,1.02,1.03,1.05,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",31,"G",0.58,0.67,2.34,1.02,1.07,0.99,75.07,5.52,-0.4]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",32,"Q",0.59,1.41,3.16,0.99,1.08,0.96,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",33,"D",0.61,1.41,5.33,1.04,1.08,0.92,133.1,3.8,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",34,"M",0.6,2.47,5.33,1.04,1.06,0.92,149.21,5.28,1.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",35,"E",0.58,1.06,3.99,0.89,1.05,1,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",36,"Q",0.54,0.47,2.6,0.82,1.04,1.05,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",37,"Q",0.51,0.41,-0.14,0.7,1.01,1.08,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",38,"V",0.47,0.32,1.39,0.82,0.98,1.11,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",39,"V",0.46,0.18,-0.33,0.8,0.95,1.1,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",40,"F",0.44,0.14,-0.26,0.86,0.93,1.1,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",41,"S",0.42,0.16,-2.43,0.81,0.92,1.11,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",42,"M",0.41,0.16,-2.43,0.81,0.93,1.11,149.21,5.28,1.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",43,"S",0.44,0.33,-1.04,0.88,0.93,1.06,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",44,"F",0.46,0.24,1.09,1.01,0.95,1.03,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",45,"V",0.5,0.43,1.27,0.92,0.98,1.01,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",46,"Q",0.53,0.55,2.99,0.94,1.02,1.01,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",47,"G",0.55,0.85,2.99,0.94,1.07,1.01,75.07,5.52,-0.4]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",48,"E",0.56,1.84,5.3,1.07,1.1,0.97,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",49,"E",0.58,1.78,7.26,1.21,1.11,0.89,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",50,"S",0.58,3.59,7.21,1.21,1.11,0.88,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",51,"N",0.56,1.45,5.26,1.06,1.1,0.92,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",52,"D",0.52,1.3,4.44,1.17,1.07,0.95,133.1,3.8,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",53,"K",0.49,0.72,2.8,1.14,1.04,1.03,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",54,"I",0.45,0.45,2.17,1.03,1,1.03,131.17,5.52,4.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",55,"P",0.42,0.22,-0.14,0.89,0.97,1.1,115.13,5.96,-1.6]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",56,"V",0.39,0.11,-0.76,0.9,0.94,1.1,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",57,"A",0.39,0.13,-2.89,0.84,0.93,1.15,89.09,5.57,1.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",58,"L",0.39,0.17,-0.93,0.92,0.94,1.12,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",59,"G",0.39,0.39,-0.11,0.81,0.97,1.09,75.07,5.52,-0.4]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",60,"L",0.41,0.78,1.23,0.88,1,1.02,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",61,"K",0.43,1.51,1.93,1.01,1.03,0.98,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",62,"E",0.44,1.26,1.93,1.01,1.05,0.98,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",63,"K",0.44,2.39,0.84,0.95,1.04,1.02,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",64,"N",0.44,0.99,0.84,0.95,1.01,1.02,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",65,"L",0.44,0.76,0.96,1.01,0.97,1.03,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",66,"Y",0.43,0.2,0.04,1.07,0.93,1.11,181.19,5.52,-1.3]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",67,"L",0.43,0.09,-1.3,1,0.92,1.18,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",68,"S",0.43,0.09,-3.61,0.86,0.91,1.25,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",69,"C",0.43,0.12,-1.49,0.92,0.92,1.2,121.15,5.52,2.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",70,"V",0.43,0.24,0.21,0.97,0.95,1.16,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",71,"L",0.44,0.3,2.96,1.09,0.98,1.1,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",72,"K",0.45,1.14,2.84,1.03,1.01,1.09,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",73,"D",0.46,2.37,2.94,1.08,1.03,1.04,133.1,3.8,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",74,"D",0.45,4.14,4.21,1.14,1.05,0.97,133.1,3.8,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",75,"K",0.45,1.71,4.21,1.14,1.05,0.97,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",76,"P",0.44,1.77,4.26,1.14,1.04,0.99,115.13,5.96,-1.6]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",77,"T",0.45,0.87,1.51,1.02,1.01,1.04,119.12,5.19,-0.7]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",78,"L",0.46,0.76,1.2,0.91,0.99,1.04,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",79,"Q",0.48,0.66,1.31,0.97,0.98,1.05,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",80,"L",0.49,0.34,0.49,0.83,0.98,1.1,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",81,"E",0.5,0.68,1.17,0.9,1,1.09,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",82,"S",0.52,0.61,2.79,1.03,1.02,1.06,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",83,"V",0.55,1.48,2.74,1.04,1.04,1.05,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",84,"D",0.56,1.37,5.06,1.17,1.05,0.98,133.1,3.8,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",85,"P",0.59,1.61,3.67,1.23,1.05,1.03,115.13,5.96,-1.6]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",86,"K",0.59,3.35,3.04,1.24,1.05,1.03,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",87,"N",0.59,4.01,4.39,1.32,1.04,0.97,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",88,"Y",0.58,5.18,3.77,1.25,1.04,0.98,181.19,5.52,-1.3]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",89,"P",0.56,5.18,4.29,1.18,1.05,0.96,115.13,5.96,-1.6]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",90,"K",0.55,3.19,2.87,1.12,1.06,0.95,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",91,"K",0.53,3.52,2.99,1,1.06,0.96,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",92,"K",0.52,4.56,4.07,0.99,1.06,0.92,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",93,"M",0.51,4.46,4.37,0.9,1.04,0.9,149.21,5.28,1.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",94,"E",0.49,1.93,2.24,0.85,1.03,0.92,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",95,"K",0.48,0.72,0.9,0.77,1.02,0.98,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",96,"R",0.46,0.63,-1.23,0.71,0.99,1.01,174.2,9.75,-4.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",97,"F",0.45,0.58,0.37,0.85,0.97,1,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",98,"V",0.46,0.58,0.07,0.89,0.96,1.01,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",99,"F",0.47,0.21,-1.89,0.81,0.96,1.04,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",100,"N",0.49,0.42,-1.37,0.78,0.98,1.04,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",101,"K",0.5,0.39,-1.2,0.76,1,1.05,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",102,"I",0.51,0.73,0.33,0.92,1,0.96,131.17,5.52,4.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",103,"E",0.54,0.73,2.64,1.05,1,0.92,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",104,"I",0.54,0.73,2.46,0.97,1.01,0.94,131.17,5.52,4.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",105,"N",0.56,0.86,0.33,0.91,1.02,0.98,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",106,"N",0.54,0.86,2.59,0.95,1.03,0.94,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",107,"K",0.54,1.06,0.16,0.93,1.02,0.98,146.19,8.75,-3.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",108,"L",0.51,1.15,2.41,0.97,1,0.93,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",109,"E",0.49,0.95,2.34,0.95,0.99,0.97,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",110,"F",0.48,0.48,1.64,0.82,0.99,1.01,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",111,"E",0.47,1.01,1.69,0.82,0.99,1.02,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",112,"S",0.45,0.51,1.69,0.82,0.99,1,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",113,"A",0.45,0.9,0.87,0.93,0.99,1.03,89.09,5.57,1.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",114,"Q",0.42,0.84,3.19,1.07,0.99,0.98,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",115,"F",0.42,0.66,0.64,1.1,0.98,0.99,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",116,"P",0.39,1.02,-0.56,1.06,0.98,1.01,115.13,5.96,-1.6]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",117,"N",0.39,0.41,-2,1.03,0.96,1.02,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",118,"W",0.38,0.64,-1.93,1.1,0.95,1.02,204.23,5.52,-0.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",119,"Y",0.37,0.6,0.13,1.15,0.94,1,181.19,5.52,-1.3]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",120,"I",0.38,0.5,0.76,1.14,0.96,0.99,131.17,5.52,4.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",121,"S",0.39,0.82,0.61,1.05,1,1.02,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",122,"T",0.41,0.53,2.34,1.01,1.04,1.05,119.12,5.19,-0.7]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",123,"S",0.43,1.31,3.73,0.95,1.07,1,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",124,"Q",0.45,1.57,5.87,1.11,1.06,0.95,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",125,"A",0.47,1.07,4.34,0.99,1.05,0.92,89.09,5.57,1.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",126,"E",0.48,1.24,3.9,1.07,1.02,0.94,147.13,4,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",127,"N",0.49,0.53,2.44,0.94,0.99,1,132.12,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",128,"M",0.48,0.46,0.27,0.88,0.97,1.01,149.21,5.28,1.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",129,"P",0.45,0.22,-1.34,0.87,0.95,1.03,115.13,5.96,-1.6]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",130,"V",0.45,0.13,-1.64,0.99,0.94,1.04,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",131,"F",0.45,0.13,-1.83,0.99,0.96,1.05,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",132,"L",0.46,0.09,-0.41,1.13,1,1.06,131.17,5.52,3.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",133,"G",0.47,0.11,0.1,1.13,1.04,1.03,75.07,5.52,-0.4]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",134,"G",0.49,0.23,1.49,1.2,1.09,0.98,75.07,5.52,-0.4]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",135,"G",0.51,0.46,4.23,1.32,1.12,0.95,75.07,5.52,-0.4]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",136,"G",0.52,0.33,4.4,1.31,1.12,0.93,75.07,5.52,-0.4]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",137,"Q",0.54,0.48,4.33,1.22,1.11,0.94,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",138,"D",0.54,0.8,4.94,1.21,1.09,0.94,133.1,3.8,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",139,"I",0.52,0.7,2.81,1.07,1.06,0.97,131.17,5.52,4.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",140,"T",0.49,0.59,2.74,0.98,1.04,0.97,119.12,5.19,-0.7]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",141,"D",0.49,0.35,1.29,0.93,1.01,0.95,133.1,3.8,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",142,"F",0.48,0.86,0.71,0.86,0.98,0.97,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",143,"T",0.47,0.52,0.54,0.88,0.95,0.96,119.12,5.19,-0.7]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",144,"M",0.47,0.23,-0.73,0.81,0.93,1.03,149.21,5.28,1.9]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",145,"Q",0.47,0.35,-1.23,0.81,0.93,1.05,146.15,5.52,-3.5]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",146,"F",0.41,0.33,1.01,0.93,0,1.04,165.19,5.52,2.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",147,"V",0.38,0,0,0,0,0,117.15,5.49,4.2]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",148,"S",0.33,0,0,0,0,0,105.09,5.24,-0.8]
["5BVP_A Chain A of The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",149,"S",0.29,0,0,0,0,0,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",1,"V",0.27,0,0,0,0,0,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",2,"E",0.33,0,0,0,0,0,147.13,4,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",3,"C",0.39,0.34,0,0,0,0,121.15,5.52,2.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",4,"D",0.45,0.71,2.13,1.06,0.96,1.1,133.1,3.8,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",5,"F",0.52,0.34,1.34,1.08,0.98,1.08,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",6,"S",0.53,0.52,-1.09,1.05,1,1.13,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",7,"P",0.54,0.42,-0.36,1.09,1.01,1.08,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",8,"L",0.54,0.48,-0.97,1.1,1.02,1.08,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",9,"L",0.53,0.52,1.09,1.15,1.03,1.05,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",10,"S",0.53,0.52,0.46,1.17,1.04,1.06,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",11,"G",0.53,0.97,0.46,1.17,1.06,1.06,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",12,"T",0.52,2.03,2.63,1.22,1.07,1.03,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",13,"P",0.52,1.12,3.41,1.21,1.06,1.05,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",14,"P",0.51,1.78,2.21,1.17,1.03,1.07,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",15,"Q",0.5,1.98,2.4,1.17,1,1.05,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",16,"V",0.5,1.11,0.34,1.12,0.97,1.08,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",17,"Y",0.5,1.44,0.86,1.04,0.96,1.06,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",18,"N",0.51,1.62,1.16,0.96,0.96,1.03,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",19,"F",0.51,1.8,-1.01,0.91,0.97,1.07,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",20,"K",0.49,0.85,-1.01,0.91,0.99,1.07,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",21,"R",0.49,0.46,-2.06,0.83,0.99,1.06,174.2,9.75,-4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",22,"L",0.5,0.77,-2.31,0.74,0.98,1.08,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",23,"V",0.5,0.62,0,0.88,0.97,1.03,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",24,"F",0.52,0.17,-0.61,0.91,0.97,1.1,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",25,"T",0.53,0.33,-0.21,0.99,0.97,1.09,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",26,"N",0.54,0.69,0.83,1.07,0.98,1.07,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",27,"C",0.54,1.29,2.36,1.22,0.97,0.99,121.15,5.52,2.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",28,"N",0.55,0.74,2.36,1.22,0.96,1.01,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",29,"Y",0.57,0.66,2.36,1.22,0.96,1.01,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",30,"N",0.56,2.47,2.17,1.14,0.97,1.03,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",31,"L",0.56,1.27,0.66,1.06,0.99,1.01,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",32,"T",0.56,0.67,-1.66,0.92,1,1.08,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",33,"K",0.55,0.56,-0.46,0.96,1,1.05,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",34,"L",0.55,0.56,-2.77,0.82,0.99,1.12,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",35,"L",0.55,0.33,-2.77,0.82,0.97,1.1,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",36,"S",0.56,0.22,-2.59,0.89,0.95,1.11,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",37,"L",0.57,0.2,-3.93,0.82,0.94,1.18,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",38,"F",0.57,0.39,-1.61,0.96,0.94,1.11,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",39,"S",0.58,0.49,1.13,1.08,0.96,1.06,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",40,"V",0.58,0.51,-1.11,0.96,0.98,1.07,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",41,"N",0.57,0.85,0.94,1.02,0.99,1.02,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",42,"D",0.58,0.34,2.46,1.1,0.99,1.06,133.1,3.8,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",43,"F",0.57,0.62,2.46,1.1,0.98,1.06,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",44,"T",0.56,0.66,3.84,1.17,0.98,1.01,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",45,"C",0.57,0.28,1.7,1.01,0.99,1.07,121.15,5.52,2.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",46,"S",0.55,0.43,1.2,1.01,1,1.09,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",47,"Q",0.54,0.46,2.81,1.14,1.02,1.08,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",48,"I",0.54,0.87,2.37,1.1,1.03,1.1,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",49,"S",0.52,0.66,2.47,1.02,1.02,1.05,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",50,"P",0.51,0.27,0.4,0.88,1,1.07,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",51,"A",0.51,0.38,-0.16,0.84,0.97,1.08,89.09,5.57,1.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",52,"A",0.51,0.38,1.91,0.98,0.95,1.06,89.09,5.57,1.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",53,"I",0.52,0.4,1.99,0.99,0.94,1.03,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",54,"A",0.53,0.21,1.89,0.95,0.95,1.08,89.09,5.57,1.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",55,"S",0.55,0.33,1.31,1.02,0.96,1.09,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",56,"N",0.55,0.63,1.94,1.13,0.97,1.08,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",57,"C",0.56,0.83,4.01,1.26,0.97,1.06,121.15,5.52,2.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",58,"Y",0.57,0.51,2.4,1.25,0.98,1.09,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",59,"S",0.58,0.22,0.33,1.12,0.98,1.11,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",60,"S",0.57,0.34,-1.99,0.98,0.98,1.18,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",61,"L",0.56,0.37,-0.76,1.02,0.97,1.1,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",62,"I",0.55,0.43,-0.76,1.02,0.95,1.1,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",63,"L",0.54,0.28,-3,0.9,0.94,1.11,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",64,"D",0.53,0.45,-3,0.9,0.93,1.11,133.1,3.8,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",65,"Y",0.52,1,-1.96,0.98,0.93,1.1,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",66,"F",0.52,1.88,-0.51,1.13,0.93,1.09,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",67,"S",0.53,0.93,-0.51,1.13,0.93,1.09,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",68,"Y",0.54,0.8,-1.01,1.12,0.94,1.11,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",69,"P",0.55,0.91,-1.34,1.04,0.94,1.06,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",70,"L",0.56,1.36,0.79,1.1,0.95,1.04,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",71,"S",0.57,1.16,0.79,1.1,0.97,1.04,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",72,"M",0.58,1.25,2.49,1.15,1.01,0.99,149.21,5.28,1.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",73,"K",0.59,1.25,0.87,1.02,1.04,1.02,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",74,"S",0.61,1.25,3.11,1.14,1.05,0.99,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",75,"D",0.63,0.94,1.66,1,1.04,1.04,133.1,3.8,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",76,"L",0.63,0.63,3.19,1.12,1.02,1.07,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",77,"S",0.62,0.63,3.3,1.18,1,1.08,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",78,"V",0.61,0.38,2.67,1.07,1,1.09,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",79,"S",0.59,0.46,2.06,1.09,1.01,1.09,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",80,"S",0.58,0.53,3.67,1.22,1.03,1.06,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",81,"A",0.58,0.5,1.6,1.08,1.04,1.08,89.09,5.57,1.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",82,"G",0.57,0.5,3.06,1.21,1.05,1.03,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",83,"P",0.56,0.64,2.99,1.15,1.05,1.03,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",84,"I",0.55,0.55,0.74,1.03,1.03,1.04,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",85,"S",0.55,0.9,1.44,1.16,1.02,1,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",86,"Q",0.56,0.91,0.36,1.1,1,1.04,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",87,"F",0.57,2.59,0.87,1.03,0.98,1.02,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",88,"N",0.58,3.35,2.87,1.1,0.99,1,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",89,"Y",0.58,2.59,2.87,1.1,1.01,1,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",90,"K",0.58,2.59,0.7,1.05,1.03,1.01,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",91,"Q",0.58,2.16,2.94,1.16,1.05,1,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",92,"S",0.57,2.22,2.94,1.16,1.05,1,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",93,"F",0.57,1.71,3.51,1.22,1.04,0.99,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",94,"S",0.57,1.43,3.44,1.21,1.05,0.98,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",95,"N",0.56,0.57,2.79,1.24,1.04,1.04,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",96,"P",0.54,0.54,0.54,1.12,1.03,1.07,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",97,"T",0.53,0.28,0.71,1.1,1,1.08,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",98,"C",0.52,0.15,-1.53,0.98,0.96,1.12,121.15,5.52,2.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",99,"L",0.51,0.1,-2.23,0.85,0.93,1.16,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",100,"I",0.5,0.1,-1.79,0.77,0.92,1.14,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",101,"L",0.51,0.13,-3.06,0.71,0.92,1.2,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",102,"A",0.51,0.25,-2.96,0.76,0.93,1.15,89.09,5.57,1.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",103,"T",0.52,0.48,-1.34,0.81,0.94,1.13,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",104,"V",0.51,0.94,0.8,0.96,0.95,1.08,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",105,"P",0.52,0.76,0.8,0.96,0.95,1.08,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",106,"H",0.53,0.76,1.24,1.01,0.96,1.06,155.16,6.74,-3.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",107,"N",0.54,1.49,1.24,1.01,0.97,1.06,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",108,"L",0.53,0.67,0.63,1,0.99,1.02,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",109,"T",0.54,0.72,1.07,0.92,1.01,1,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",110,"T",0.53,0.89,1.59,0.93,1.03,0.98,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",111,"I",0.52,1.67,0.89,0.92,1.04,1.02,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",112,"T",0.5,0.95,0.89,0.92,1.05,1.02,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",113,"K",0.51,1.32,0.96,0.93,1.05,1.02,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",114,"P",0.5,2.95,-0.06,0.96,1.04,1.06,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",115,"L",0.5,2.74,2.01,1.09,1.02,1.04,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",116,"K",0.51,2.15,1,1.12,1,1.07,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",117,"Y",0.52,0.97,-0.96,1.04,0.97,1.1,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",118,"S",0.53,1.9,-0.26,1.05,0.95,1.06,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",119,"Y",0.53,1.9,1.87,1.11,0.95,1.02,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",120,"I",0.53,0.65,1.26,1.13,0.96,1.09,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",121,"N",0.55,0.65,2.46,1.18,0.98,1.06,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",122,"K",0.55,0.81,2.13,1.11,1,1.05,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",123,"C",0.56,1,1.09,1.03,1.01,1.04,121.15,5.52,2.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",124,"S",0.56,0.51,0.91,1.05,1.01,1.05,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",125,"R",0.56,0.34,0.84,1.03,1,1.08,174.2,9.75,-4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",126,"F",0.56,1.07,1.46,1.09,0.99,1.07,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",127,"L",0.56,1.34,2.69,1.13,1,1,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",128,"S",0.56,1.34,2.36,1.06,1.01,0.98,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",129,"D",0.56,2.23,2.5,1.06,1.02,0.98,133.1,3.8,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",130,"D",0.54,4.68,4.93,1.08,1.04,0.95,133.1,3.8,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",131,"R",0.53,2.59,5.71,1.07,1.04,0.97,174.2,9.75,-4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",132,"T",0.53,2.4,5.09,1.08,1.04,0.97,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",133,"E",0.53,2.49,4.51,1.02,1.04,0.99,147.13,4,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",134,"V",0.53,1.05,1.77,0.89,1.03,1.05,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",135,"P",0.53,0.54,0.64,0.83,1.02,1.12,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",136,"Q",0.53,0.5,0.9,0.91,1,1.1,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",137,"L",0.55,0.68,0.09,0.9,0.99,1.13,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",138,"V",0.57,0.71,1.61,1.05,0.98,1.05,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",139,"N",0.59,0.71,2.17,0.98,0.98,1.04,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",140,"A",0.61,1.35,1.04,1,0.99,1.06,89.09,5.57,1.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",141,"N",0.6,2.43,3.29,1.12,1,1.03,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",142,"Q",0.6,2.34,4.11,1.26,1.01,0.98,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",143,"Y",0.6,1.24,3.31,1.21,1.01,1.07,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",144,"S",0.59,0.57,2.49,1.19,1,1.12,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",145,"P",0.58,0.44,2.41,1.17,0.99,1.15,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",146,"C",0.55,0.2,0.41,1.1,0.96,1.17,121.15,5.52,2.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",147,"V",0.52,0.11,0.16,1.01,0.94,1.2,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",148,"S",0.51,0.11,-0.47,1.02,0.93,1.21,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",149,"I",0.51,0.27,0.16,1.01,0.95,1.2,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",150,"V",0.51,0.53,0.7,0.97,0.99,1.13,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",151,"P",0.51,0.3,0.7,0.97,1.02,1.13,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",152,"S",0.51,0.44,-1.66,0.91,1.04,1.11,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",153,"T",0.51,1.03,0.6,0.94,1.03,1.07,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",154,"V",0.51,1.12,2.56,1.08,1.01,1,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",155,"W",0.52,0.83,3.07,1.09,1,0.97,204.23,5.52,-0.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",156,"E",0.52,0.95,3.57,1.09,1.02,0.95,147.13,4,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",157,"D",0.52,2.02,2.56,1.12,1.03,0.98,133.1,3.8,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",158,"G",0.51,3,2.81,1.21,1.04,0.95,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",159,"D",0.52,3.4,4.84,1.21,1.04,0.95,133.1,3.8,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",160,"Y",0.52,4.07,4.54,1.25,1.02,0.96,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",161,"Y",0.52,7.12,3.97,1.18,1.01,0.98,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",162,"R",0.53,3.52,1.84,1.04,1.01,1.04,174.2,9.75,-4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",163,"K",0.53,3.01,1.34,1.03,1.02,1.06,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",164,"Q",0.53,2.97,1.91,1.09,1.03,1.04,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",165,"L",0.55,1.25,0.87,1.01,1.03,1.06,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",166,"S",0.55,1.08,1.39,0.98,1.03,1.05,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",167,"P",0.56,0.62,1.39,1.06,1.04,1.05,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",168,"L",0.55,0.74,1.34,1.14,1.04,1.02,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",169,"E",0.54,0.55,3.47,1.28,1.06,0.97,147.13,4,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",170,"G",0.54,0.37,1.11,1.21,1.07,0.95,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",171,"G",0.54,0.37,-0.5,1.08,1.06,0.98,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",172,"G",0.54,0.16,0.29,1.07,1.03,1,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",173,"W",0.56,0.16,-0.53,1.06,0.98,1.03,204.23,5.52,-0.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",174,"L",0.56,0.22,-0.41,1.04,0.96,1.05,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",175,"V",0.58,0.22,-0.41,1.04,0.96,1.05,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",176,"A",0.58,0.28,-0.3,1.02,0.99,1.07,89.09,5.57,1.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",177,"S",0.59,0.49,1.87,1.02,1.04,1.07,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",178,"G",0.6,0.49,2.66,1.01,1.07,1.09,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",179,"S",0.61,0.49,3.49,1.03,1.07,1.05,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",180,"T",0.62,0.36,2.59,1.02,1.03,1.01,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",181,"V",0.63,0.53,2.4,0.95,0.99,1,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",182,"A",0.63,0.69,2.7,0.84,0.96,0.99,89.09,5.57,1.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",183,"M",0.63,0.82,2.63,0.77,0.96,0.99,149.21,5.28,1.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",184,"T",0.62,0.91,0.57,0.72,0.99,1.04,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",185,"E",0.63,1.57,1.96,0.79,1,0.99,147.13,4,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",186,"Q",0.62,1.57,1.06,0.78,1,0.96,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",187,"L",0.61,1.07,2.47,0.92,0.98,0.96,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",188,"Q",0.59,0.54,0.41,0.86,0.95,0.99,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",189,"M",0.57,0.31,0.11,0.98,0.93,0.99,149.21,5.28,1.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",190,"G",0.56,0.26,-1.89,0.91,0.93,1.01,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",191,"F",0.55,0.22,0.17,0.96,0.94,0.96,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",192,"G",0.55,0.16,-1.21,0.89,0.95,1.02,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",193,"I",0.55,0.29,0.24,0.95,0.95,1.04,131.17,5.52,4.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",194,"T",0.54,0.52,-0.84,0.89,0.95,1.08,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",195,"V",0.55,0.52,1.29,1.02,0.95,1.05,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",196,"Q",0.56,1.06,1.21,0.94,0.96,1.06,146.15,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",197,"Y",0.57,1.06,3.1,1.01,0.98,1.02,181.19,5.52,-1.3]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",198,"G",0.59,2.3,3.36,1.09,1.02,1,75.07,5.52,-0.4]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",199,"T",0.59,1.78,4.81,1.23,1.05,0.95,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",200,"T",0.58,0.84,3.43,1.16,1.06,1,119.12,5.19,-0.7]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",201,"N",0.57,0.46,3.9,1.17,1.05,1.04,132.12,5.52,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",202,"S",0.57,0.49,3.39,1.16,1.02,1.07,105.09,5.24,-0.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",203,"V",0.56,0.68,3.46,1.17,1,1.07,117.15,5.49,4.2]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",204,"C",0.57,0.35,1.4,1.11,0.99,1.12,121.15,5.52,2.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",205,"P",0.56,0.45,1.51,1,1,1.13,115.13,5.96,-1.6]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",206,"K",0.56,0.52,-0.73,0.88,1,1.14,146.19,8.75,-3.9]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",207,"L",0.5,0.99,0.1,0.9,0,1.09,131.17,5.52,3.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",208,"E",0.44,0,0,0,0,0,147.13,4,-3.5]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",209,"F",0.38,0,0,0,0,0,165.19,5.52,2.8]
["4XAK_A Chain A of Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD",210,"A",0.32,0,0,0,0,0,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",1,"R",0.18,0,0,0,0,0,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",2,"S",0.22,0,0,0,0,0,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",3,"T",0.27,1.31,0,0,0,0,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",4,"T",0.29,0.67,0.69,0.88,1.03,1.04,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",5,"L",0.32,0.42,-1.23,0.83,0.99,1.09,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",6,"L",0.31,0.24,-3.47,0.71,0.95,1.13,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",7,"A",0.31,0.17,-3.91,0.66,0.93,1.15,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",8,"L",0.3,0.17,-5.97,0.61,0.91,1.2,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",9,"L",0.29,0.15,-5.19,0.6,0.91,1.22,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",10,"A",0.28,0.12,-5.19,0.6,0.91,1.22,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",11,"L",0.27,0.12,-6.8,0.59,0.91,1.24,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",12,"V",0.25,0.23,-5.76,0.67,0.91,1.23,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",13,"L",0.25,0.19,-5.76,0.67,0.91,1.23,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",14,"L",0.27,0.17,-6.59,0.64,0.9,1.28,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",15,"Y",0.28,0.31,-4.34,0.76,0.91,1.24,181.19,5.52,-1.3]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",16,"L",0.29,0.37,-3,0.91,0.93,1.17,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",17,"V",0.31,0.45,-1.39,0.92,0.95,1.14,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",18,"S",0.32,0.24,-1.39,0.92,0.97,1.14,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",19,"G",0.31,0.21,-1.64,0.83,0.98,1.17,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",20,"A",0.33,0.25,-1.64,0.83,0.96,1.15,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",21,"L",0.35,0.37,-0.51,0.9,0.94,1.08,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",22,"V",0.36,0.37,-1.14,0.79,0.93,1.09,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",23,"F",0.37,0.3,-3.27,0.65,0.92,1.14,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",24,"R",0.4,0.64,-2.46,0.66,0.93,1.11,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",25,"A",0.43,1.49,-0.29,0.72,0.96,1.08,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",26,"L",0.44,2.66,0.54,0.86,0.99,1.03,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",27,"E",0.46,1.85,2.16,0.91,1.03,1.03,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",28,"Q",0.51,3.17,2.67,0.88,1.06,1.03,146.15,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",29,"P",0.52,6.66,3.23,0.93,1.07,1.02,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",30,"H",0.53,6.66,5.4,0.98,1.06,0.99,155.16,6.74,-3.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",31,"E",0.57,3.88,4.59,0.97,1.06,1.02,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",32,"Q",0.59,4.35,4.59,0.97,1.06,1.02,146.15,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",33,"Q",0.59,6.26,4.89,0.89,1.05,0.99,146.15,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",34,"A",0.57,6.26,5.7,0.86,1.05,0.95,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",35,"Q",0.57,2.98,3.27,0.84,1.04,1.01,146.15,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",36,"R",0.57,1.7,3.23,0.92,1.03,0.99,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",37,"E",0.57,2.92,3.49,0.89,1.02,0.97,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",38,"L",0.57,1.25,2.66,0.87,1.02,1.01,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",39,"G",0.58,1.25,2.4,0.86,1.02,0.99,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",40,"E",0.57,1.25,2.91,0.83,1.02,0.99,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",41,"V",0.54,3.04,2.61,0.87,1.03,1,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",42,"R",0.53,2.66,2.61,0.87,1.03,0.98,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",43,"E",0.55,1.27,0.49,0.73,1.03,1.03,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",44,"K",0.55,3.34,-0.03,0.76,1.01,1.04,146.19,8.75,-3.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",45,"F",0.55,1.72,0.8,0.79,0.98,0.99,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",46,"L",0.54,1.35,0.5,0.79,0.96,1.02,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",47,"R",0.54,1.05,-0.31,0.9,0.94,1.05,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",48,"A",0.54,0.65,-0.93,0.92,0.93,1.12,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",49,"H",0.54,0.58,-0.14,0.91,0.93,1.16,155.16,6.74,-3.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",50,"P",0.57,0.4,2.1,1.03,0.93,1.13,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",51,"C",0.57,0.66,2.93,1.1,0.94,1.13,121.15,5.52,2.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",52,"V",0.58,0.84,3.49,1.15,0.97,1.12,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",53,"S",0.58,0.94,4.3,1.12,1.01,1.09,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",54,"D",0.58,1.45,2.69,0.98,1.03,1.11,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",55,"Q",0.58,1.93,3.3,1.04,1.05,1.04,146.15,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",56,"E",0.55,1.19,2.51,1.05,1.03,1.02,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",57,"L",0.53,0.59,0.27,0.93,1,1.05,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",58,"G",0.53,0.24,-2.3,0.79,0.97,1.09,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",59,"L",0.51,0.27,-2.34,0.79,0.95,1.08,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",60,"L",0.47,0.57,-2.34,0.79,0.95,1.08,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",61,"I",0.44,0.43,-1.56,0.78,0.96,1.1,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",62,"K",0.44,0.53,-2.07,0.65,0.98,1.13,146.19,8.75,-3.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",63,"E",0.43,1.07,0.67,0.78,0.98,1.07,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",64,"V",0.42,1.54,2.29,0.79,0.97,1.04,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",65,"A",0.44,0.64,2.11,0.8,0.96,1.06,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",66,"D",0.46,0.36,2.11,0.88,0.95,1.05,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",67,"A",0.46,0.48,1.81,1,0.97,1.05,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",68,"L",0.47,0.47,3.16,1.15,1,0.98,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",69,"G",0.51,0.29,3.16,1.15,1.03,0.98,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",70,"G",0.53,0.47,3.16,1.15,1.05,0.98,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",71,"G",0.55,0.89,3.16,1.27,1.06,0.98,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",72,"A",0.59,1.56,5.59,1.29,1.07,0.92,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",73,"D",0.62,2.27,5.51,1.21,1.07,0.93,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",74,"P",0.63,3.07,5.63,1.19,1.07,0.95,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",75,"E",0.65,4.14,5.11,1.1,1.07,0.98,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",76,"T",0.65,3.32,5.74,1.21,1.05,0.97,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",77,"S",0.65,2.17,4.61,1.1,1.02,1,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",78,"H",0.65,1.32,2.89,1.02,0.99,0.98,155.16,6.74,-3.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",79,"S",0.63,1.53,3.2,1.12,0.96,0.98,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",80,"A",0.61,0.94,1.14,1.07,0.95,1.03,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",81,"W",0.58,0.68,1.03,1.09,0.94,1.01,204.23,5.52,-0.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",82,"D",0.54,0.68,1.66,1.16,0.96,1,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",83,"L",0.52,0.68,1.03,1.05,0.98,1,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",84,"G",0.49,0.56,-0.59,1.04,0.99,1.01,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",85,"S",0.46,0.29,-0.47,0.99,0.99,1.04,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",86,"A",0.42,0.31,-3.21,0.86,0.97,1.07,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",87,"F",0.4,0.41,-0.97,0.98,0.95,1.03,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",88,"F",0.38,0.31,-0.97,0.98,0.96,1.03,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",89,"F",0.35,0.44,-1.16,0.92,0.98,1.02,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",90,"S",0.34,0.35,-2.6,0.89,1.01,1.03,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",91,"G",0.34,0.29,-2.43,0.87,1.02,1.04,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",92,"T",0.35,0.48,-0.37,0.92,1.01,1.01,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",93,"I",0.37,0.51,1.69,0.97,0.99,0.99,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",94,"I",0.39,0.36,-0.39,0.84,0.98,1.01,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",95,"T",0.44,0.25,-0.39,0.84,0.99,1.01,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",96,"T",0.48,0.56,-1.4,0.86,0.99,1.04,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",97,"I",0.5,0.79,0.56,1.02,0.99,1,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",98,"G",0.53,0.88,2.7,1.17,0.99,0.95,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",99,"Y",0.56,0.45,1.43,1.11,0.98,1.02,181.19,5.52,-1.3]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",100,"G",0.57,0.65,0.99,1.06,0.98,1.04,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",101,"N",0.6,0.54,0.81,1.08,0.97,1.05,132.12,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",102,"V",0.58,0.68,0.6,0.99,0.96,1.05,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",103,"A",0.58,0.99,1.61,0.97,0.96,1.02,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",104,"L",0.57,1.03,2.23,0.95,0.98,1.02,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",105,"R",0.55,1.4,1.53,0.83,1.01,1.06,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",106,"T",0.54,1.37,2.87,0.98,1.04,0.99,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",107,"D",0.52,3.25,3.17,1.02,1.05,0.96,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",108,"A",0.49,1.37,3.17,1.02,1.05,0.96,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",109,"G",0.47,0.82,1.26,0.97,1.03,0.99,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",110,"R",0.42,0.26,0.71,1,1,1.06,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",111,"L",0.39,0.18,-1.86,0.86,0.97,1.1,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",112,"F",0.36,0.16,-3.47,0.85,0.94,1.11,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",113,"C",0.32,0.13,-4.56,0.79,0.92,1.15,121.15,5.52,2.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",114,"I",0.3,0.16,-4.86,0.75,0.9,1.17,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",115,"F",0.28,0.15,-4.86,0.75,0.89,1.17,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",116,"Y",0.26,0.21,-4.07,0.74,0.89,1.22,181.19,5.52,-1.3]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",117,"A",0.26,0.29,-3.46,0.79,0.89,1.14,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",118,"L",0.27,0.24,-3.46,0.79,0.91,1.14,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",119,"V",0.28,0.23,-1.84,0.92,0.92,1.14,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",120,"G",0.29,0.19,-2.89,0.84,0.94,1.15,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",121,"I",0.29,0.2,-4.5,0.83,0.95,1.15,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",122,"P",0.31,0.27,-2.37,0.97,0.95,1.1,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",123,"L",0.32,0.19,-2.99,0.97,0.94,1.07,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",124,"F",0.32,0.22,-5.11,0.83,0.93,1.12,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",125,"G",0.33,0.12,-5.29,0.85,0.92,1.13,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",126,"I",0.34,0.15,-5.29,0.72,0.92,1.13,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",127,"L",0.35,0.17,-3.16,0.86,0.92,1.08,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",128,"L",0.37,0.12,-2.37,0.85,0.93,1.12,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",129,"A",0.39,0.18,-2.37,0.85,0.94,1.12,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",130,"G",0.43,0.36,0.2,0.99,0.96,1.08,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",131,"V",0.44,0.85,2.11,1.04,0.98,1.03,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",132,"G",0.46,0.69,2.11,1.04,1,1.03,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",133,"D",0.47,0.69,2.63,1.17,1.01,1,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",134,"R",0.48,1.25,2.74,1.15,1.03,1.02,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",135,"L",0.49,1.69,4.2,1.28,1.04,0.97,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",136,"G",0.5,0.83,2.07,1.14,1.05,1.02,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",137,"S",0.51,0.83,1.24,1.07,1.05,1.02,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",138,"S",0.5,1.37,0.94,1.07,1.03,1.05,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",139,"L",0.5,1.37,3.07,1.21,1,1,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",140,"R",0.49,0.72,1.11,1.05,0.97,1.04,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",141,"H",0.5,0.53,1,1.07,0.96,1.02,155.16,6.74,-3.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",142,"G",0.51,0.88,0.37,1,0.95,1.03,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",143,"I",0.52,0.31,0.54,0.99,0.95,1.02,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",144,"G",0.53,0.4,1.06,0.96,0.94,1.02,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",145,"H",0.53,0.41,1.06,0.92,0.94,1.01,155.16,6.74,-3.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",146,"I",0.53,0.41,-0.9,0.76,0.93,1.05,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",147,"E",0.54,0.36,-1.07,0.78,0.92,1.04,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",148,"A",0.55,0.22,-3.2,0.64,0.92,1.1,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",149,"I",0.57,0.62,-2.69,0.65,0.93,1.07,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",150,"F",0.59,0.37,-2.97,0.72,0.94,1.03,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",151,"L",0.6,0.5,-3.79,0.75,0.95,1.07,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",152,"K",0.61,0.53,-4.61,0.73,0.95,1.11,146.19,8.75,-3.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",153,"W",0.62,0.95,-3.17,0.88,0.96,1.1,204.23,5.52,-0.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",154,"H",0.63,1.79,-1.56,1.01,0.96,1.1,155.16,6.74,-3.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",155,"V",0.64,1.55,0.87,1.03,0.98,1.04,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",156,"P",0.65,1.21,-1.26,0.97,1,1.09,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",157,"P",0.66,0.66,-0.36,0.9,1.01,1.16,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",158,"E",0.65,1.75,-0.06,0.9,1,1.12,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",159,"L",0.64,0.84,-0.06,0.9,0.98,1.12,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",160,"V",0.64,0.45,-1.67,0.77,0.95,1.15,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",161,"R",0.63,0.35,-1.04,0.76,0.94,1.14,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",162,"V",0.63,0.42,-1.86,0.75,0.93,1.17,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",163,"L",0.62,0.57,-1.14,0.75,0.93,1.11,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",164,"S",0.61,0.24,-1.93,0.76,0.92,1.09,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",165,"A",0.6,0.28,-3.84,0.71,0.91,1.13,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",166,"M",0.57,0.28,-4.63,0.72,0.9,1.11,149.21,5.28,1.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",167,"L",0.56,0.17,-4.63,0.72,0.9,1.11,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",168,"F",0.53,0.12,-6.7,0.59,0.9,1.13,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",169,"L",0.49,0.12,-6.19,0.71,0.91,1.1,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",170,"L",0.47,0.08,-5.39,0.8,0.91,1.18,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",171,"I",0.43,0.07,-5.39,0.8,0.91,1.18,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",172,"G",0.4,0.07,-5.39,0.8,0.91,1.21,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",173,"C",0.36,0.08,-5.39,0.8,0.91,1.18,121.15,5.52,2.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",174,"L",0.31,0.08,-4.6,0.79,0.91,1.2,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",175,"L",0.28,0.07,-4.77,0.8,0.92,1.22,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",176,"F",0.26,0.18,-4.84,0.72,0.93,1.22,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",177,"V",0.26,0.34,-4.74,0.76,0.95,1.17,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",178,"L",0.26,0.6,-2.69,0.82,0.98,1.12,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",179,"T",0.26,0.6,-2.69,0.82,1,1.1,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",180,"P",0.26,0.6,-1.9,0.8,1.01,1.14,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",181,"T",0.27,0.63,-2.69,0.82,0.99,1.1,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",182,"F",0.3,0.23,-1.17,0.9,0.97,1.12,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",183,"V",0.34,0.24,-2.19,0.93,0.94,1.16,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",184,"F",0.38,0.16,-3.09,0.8,0.91,1.12,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",185,"C",0.42,0.33,-2.71,0.77,0.9,1.12,121.15,5.52,2.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",186,"Y",0.45,0.73,0.03,0.89,0.91,1.08,181.19,5.52,-1.3]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",187,"M",0.48,0.89,-0.87,0.96,0.93,1.01,149.21,5.28,1.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",188,"E",0.51,2.22,1.37,1.07,0.97,1,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",189,"D",0.53,2.84,1.99,1.05,1,0.93,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",190,"W",0.54,2.36,0.94,0.97,1.01,0.95,204.23,5.52,-0.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",191,"S",0.53,2.36,2.66,0.99,1.02,0.95,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",192,"K",0.52,1.43,1.84,0.98,1.01,0.98,146.19,8.75,-3.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",193,"L",0.47,0.95,-0.73,0.84,0.98,1.02,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",194,"E",0.43,1.12,0.43,0.86,0.95,1.06,147.13,4,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",195,"A",0.39,0.48,-1.81,0.74,0.93,1.07,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",196,"I",0.35,0.43,-3.16,0.67,0.9,1.14,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",197,"Y",0.32,0.19,-2.37,0.66,0.89,1.15,181.19,5.52,-1.3]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",198,"F",0.29,0.27,-2.74,0.69,0.9,1.16,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",199,"V",0.26,0.31,-4.36,0.68,0.91,1.19,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",200,"V",0.25,0.29,-2.47,0.75,0.93,1.16,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",201,"T",0.24,0.48,-1.46,0.72,0.96,1.12,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",202,"L",0.26,0.48,-0.67,0.71,0.98,1.16,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",203,"T",0.28,0.64,0.67,0.86,1,1.09,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",204,"T",0.32,0.38,-0.11,0.88,1,1.05,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",205,"V",0.35,0.46,-0.04,0.96,0.99,1.04,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",206,"G",0.37,0.53,2.7,1.09,0.98,0.99,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",207,"F",0.4,0.58,1.69,1.11,0.98,1.02,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",208,"G",0.43,0.58,0.41,1.05,0.99,1.09,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",209,"D",0.46,0.59,1.24,1.07,0.99,1.04,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",210,"Y",0.49,0.68,1.24,1.07,0.97,1.04,181.19,5.52,-1.3]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",211,"V",0.51,0.69,2.86,1.08,0.96,1.04,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",212,"A",0.54,0.69,3.47,1.06,0.96,1.04,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",213,"G",0.56,0.68,2.34,1.07,0.98,1.07,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",214,"A",0.58,1.8,3.21,1.04,1.01,1.03,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",215,"D",0.59,3.08,4.6,1.11,1.04,0.97,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",216,"P",0.6,5.2,5.73,1.23,1.06,0.95,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",217,"R",0.62,6.9,5.84,1.21,1.08,0.97,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",218,"Q",0.64,6.39,5.84,1.33,1.09,0.97,146.15,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",219,"D",0.64,4.17,4.71,1.22,1.09,0.99,133.1,3.8,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",220,"S",0.63,3.34,4.14,1.16,1.08,1.01,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",221,"P",0.61,3.34,4.4,1.17,1.05,1.03,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",222,"A",0.58,3.09,3.84,1.24,1.02,1.04,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",223,"Y",0.55,1.9,1.1,1.12,1.01,1.09,181.19,5.52,-1.3]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",224,"Q",0.52,0.91,-0.36,0.99,1,1.14,146.15,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",225,"P",0.49,0.95,-2.09,0.91,0.98,1.12,115.13,5.96,-1.6]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",226,"L",0.45,0.53,-3.7,0.9,0.96,1.12,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",227,"V",0.4,0.32,-4.86,0.87,0.92,1.08,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",228,"W",0.37,0.14,-6.86,0.8,0.89,1.1,204.23,5.52,-0.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",229,"F",0.33,0.14,-8.47,0.67,0.87,1.13,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",230,"W",0.3,0.16,-8.47,0.67,0.87,1.13,204.23,5.52,-0.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",231,"I",0.28,0.15,-7.13,0.82,0.88,1.06,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",232,"L",0.28,0.14,-7.01,0.77,0.91,1.11,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",233,"L",0.29,0.14,-5.4,0.77,0.92,1.1,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",234,"G",0.28,0.31,-4.24,0.8,0.92,1.14,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",235,"L",0.27,0.32,-4.41,0.82,0.92,1.13,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",236,"A",0.29,0.4,-2.8,0.83,0.91,1.11,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",237,"Y",0.29,0.54,-0.56,0.95,0.9,1.07,181.19,5.52,-1.3]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",238,"F",0.32,0.48,-1.9,0.8,0.91,1.15,165.19,5.52,2.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",239,"A",0.34,0.4,-1.9,0.8,0.92,1.15,89.09,5.57,1.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",240,"S",0.37,0.36,-1.46,0.84,0.93,1.12,105.09,5.24,-0.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",241,"V",0.36,0.61,-0.44,0.81,0.96,1.09,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",242,"L",0.35,0.42,-0.27,0.8,0.98,1.1,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",243,"T",0.37,0.31,0.24,0.92,1,1.07,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",244,"T",0.41,0.67,0.31,0.94,1.02,1.04,119.12,5.19,-0.7]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",245,"I",0.4,0.86,-0.59,1.01,1.02,0.97,131.17,5.52,4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",246,"G",0.43,0.49,-0.59,1.01,1.01,0.97,75.07,5.52,-0.4]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",247,"N",0.44,0.67,-0.73,1.01,0.99,0.96,132.12,5.52,-3.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",248,"W",0.43,0.71,-2,0.94,0.96,1.03,204.23,5.52,-0.9]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",249,"L",0.37,0.53,-1.39,0.95,0,1.06,131.17,5.52,3.8]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",250,"R",0.34,0,0,0,0,0,174.2,9.75,-4.5]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",251,"V",0.3,0,0,0,0,0,117.15,5.49,4.2]
["4WFF_A Chain A of Human TRAAK K+ channel in a K+ bound nonconductive conformation",252,"V",0.24,0,0,0,0,0,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",1,"R",0.19,0,0,0,0,0,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",2,"S",0.23,0,0,0,0,0,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",3,"T",0.27,1.27,0,0,0,0,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",4,"T",0.3,0.66,0.69,0.88,1.03,1.04,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",5,"L",0.32,0.4,-1.23,0.83,0.99,1.09,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",6,"L",0.32,0.23,-3.47,0.71,0.95,1.13,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",7,"A",0.31,0.16,-3.91,0.66,0.93,1.15,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",8,"L",0.3,0.16,-5.97,0.61,0.91,1.2,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",9,"L",0.29,0.15,-5.19,0.6,0.91,1.22,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",10,"A",0.29,0.12,-5.19,0.6,0.91,1.22,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",11,"L",0.28,0.12,-6.8,0.59,0.91,1.24,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",12,"V",0.26,0.23,-5.76,0.67,0.91,1.23,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",13,"L",0.25,0.18,-5.76,0.67,0.91,1.23,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",14,"L",0.27,0.17,-6.59,0.64,0.9,1.28,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",15,"Y",0.28,0.3,-4.34,0.76,0.91,1.24,181.19,5.52,-1.3]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",16,"L",0.3,0.36,-3,0.91,0.93,1.17,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",17,"V",0.32,0.44,-1.39,0.92,0.95,1.14,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",18,"S",0.33,0.23,-1.39,0.92,0.97,1.14,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",19,"G",0.31,0.21,-1.64,0.83,0.98,1.17,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",20,"A",0.33,0.24,-1.64,0.83,0.96,1.15,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",21,"L",0.36,0.36,-0.51,0.9,0.94,1.08,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",22,"V",0.37,0.36,-1.14,0.79,0.93,1.09,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",23,"F",0.38,0.3,-3.27,0.65,0.92,1.14,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",24,"R",0.41,0.62,-2.46,0.66,0.93,1.11,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",25,"A",0.44,1.45,-0.29,0.72,0.96,1.08,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",26,"L",0.46,2.59,0.54,0.86,0.99,1.03,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",27,"E",0.48,1.8,2.16,0.91,1.03,1.03,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",28,"Q",0.53,3.09,2.67,0.88,1.06,1.03,146.15,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",29,"P",0.54,6.48,3.23,0.93,1.07,1.02,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",30,"H",0.55,6.48,5.4,0.98,1.06,0.99,155.16,6.74,-3.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",31,"E",0.59,3.78,4.59,0.97,1.06,1.02,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",32,"Q",0.61,4.23,4.59,0.97,1.06,1.02,146.15,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",33,"Q",0.61,6.09,4.89,0.89,1.05,0.99,146.15,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",34,"A",0.59,6.09,5.7,0.86,1.05,0.95,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",35,"Q",0.58,2.9,3.27,0.84,1.04,1.01,146.15,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",36,"R",0.58,1.66,3.23,0.92,1.03,0.99,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",37,"E",0.58,2.84,3.49,0.89,1.02,0.97,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",38,"L",0.57,1.22,2.66,0.87,1.02,1.01,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",39,"G",0.58,1.22,2.4,0.86,1.02,0.99,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",40,"E",0.58,1.22,2.91,0.83,1.02,0.99,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",41,"V",0.55,2.95,2.61,0.87,1.03,1,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",42,"R",0.53,2.58,2.61,0.87,1.03,0.98,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",43,"E",0.55,1.23,0.49,0.73,1.03,1.03,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",44,"K",0.55,3.25,-0.03,0.76,1.01,1.04,146.19,8.75,-3.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",45,"F",0.55,1.68,0.8,0.79,0.98,0.99,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",46,"L",0.54,1.32,0.5,0.79,0.96,1.02,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",47,"R",0.54,1.02,-0.31,0.9,0.94,1.05,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",48,"A",0.53,0.63,-0.93,0.92,0.93,1.12,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",49,"H",0.53,0.57,-0.14,0.91,0.93,1.16,155.16,6.74,-3.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",50,"P",0.56,0.39,2.1,1.03,0.93,1.13,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",51,"C",0.57,0.64,2.93,1.1,0.94,1.13,121.15,5.52,2.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",52,"V",0.58,0.82,3.49,1.15,0.97,1.12,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",53,"S",0.57,0.91,4.3,1.12,1.01,1.09,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",54,"D",0.58,1.41,2.69,0.98,1.03,1.11,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",55,"Q",0.58,1.88,3.3,1.04,1.05,1.04,146.15,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",56,"E",0.55,1.15,2.51,1.05,1.03,1.02,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",57,"L",0.52,0.57,0.27,0.93,1,1.05,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",58,"G",0.51,0.23,-2.3,0.79,0.97,1.09,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",59,"L",0.49,0.27,-2.34,0.79,0.95,1.08,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",60,"L",0.46,0.56,-2.34,0.79,0.95,1.08,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",61,"I",0.43,0.42,-1.56,0.78,0.96,1.1,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",62,"K",0.42,0.51,-2.07,0.65,0.98,1.13,146.19,8.75,-3.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",63,"E",0.41,1.04,0.67,0.78,0.98,1.07,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",64,"V",0.39,1.5,2.29,0.79,0.97,1.04,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",65,"A",0.42,0.62,2.11,0.8,0.96,1.06,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",66,"D",0.44,0.35,2.11,0.88,0.95,1.05,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",67,"A",0.44,0.47,1.81,1,0.97,1.05,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",68,"L",0.44,0.46,3.16,1.15,1,0.98,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",69,"G",0.48,0.28,3.16,1.15,1.03,0.98,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",70,"G",0.5,0.46,3.16,1.15,1.05,0.98,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",71,"G",0.52,0.87,3.16,1.27,1.06,0.98,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",72,"A",0.55,1.51,5.59,1.29,1.07,0.92,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",73,"D",0.59,2.21,5.51,1.21,1.07,0.93,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",74,"P",0.62,3.87,5.56,1.13,1.08,0.95,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",75,"E",0.63,5.13,5.67,1.11,1.09,0.97,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",76,"T",0.65,4.11,6.3,1.22,1.1,0.96,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",77,"Q",0.68,3.62,5.17,1.14,1.11,1,146.15,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",78,"S",0.68,2.8,5.8,1.13,1.09,0.99,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",79,"S",0.68,1.96,4.99,1.12,1.05,1.02,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",80,"H",0.67,1.19,2.81,1.12,1.01,1.02,155.16,6.74,-3.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",81,"S",0.65,1.48,3.39,1.19,0.97,0.99,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",82,"A",0.63,0.91,1.14,1.07,0.95,1.03,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",83,"W",0.61,0.66,1.03,1.09,0.94,1.01,204.23,5.52,-0.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",84,"D",0.59,0.66,1.66,1.16,0.96,1,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",85,"L",0.55,0.66,1.03,1.05,0.98,1,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",86,"G",0.54,0.55,-0.59,1.04,0.99,1.01,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",87,"S",0.52,0.28,-0.47,0.99,0.99,1.04,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",88,"A",0.48,0.3,-3.21,0.86,0.97,1.07,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",89,"F",0.46,0.4,-0.97,0.98,0.95,1.03,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",90,"F",0.43,0.3,-0.97,0.98,0.96,1.03,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",91,"F",0.4,0.43,-1.16,0.92,0.98,1.02,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",92,"S",0.37,0.34,-2.6,0.89,1.01,1.03,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",93,"G",0.35,0.28,-2.43,0.87,1.02,1.04,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",94,"T",0.36,0.46,-0.37,0.92,1.01,1.01,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",95,"I",0.35,0.5,1.69,0.97,0.99,0.99,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",96,"I",0.36,0.35,-0.39,0.84,0.98,1.01,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",97,"T",0.38,0.24,-0.39,0.84,0.99,1.01,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",98,"T",0.41,0.54,-1.4,0.86,0.99,1.04,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",99,"I",0.44,0.77,0.56,1.02,0.99,1,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",100,"G",0.48,0.85,2.7,1.17,0.99,0.95,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",101,"Y",0.52,0.44,1.43,1.11,0.98,1.02,181.19,5.52,-1.3]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",102,"G",0.57,0.63,0.99,1.06,0.98,1.04,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",103,"N",0.6,0.53,0.81,1.08,0.97,1.05,132.12,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",104,"V",0.6,0.66,0.6,0.99,0.96,1.05,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",105,"A",0.62,0.96,1.61,0.97,0.96,1.02,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",106,"L",0.62,1,2.23,0.95,0.98,1.02,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",107,"R",0.62,1.36,1.53,0.83,1.01,1.06,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",108,"T",0.62,1.33,2.87,0.98,1.04,0.99,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",109,"D",0.6,3.16,3.17,1.02,1.05,0.96,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",110,"A",0.58,1.33,3.17,1.02,1.05,0.96,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",111,"G",0.54,0.8,1.26,0.97,1.03,0.99,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",112,"R",0.5,0.26,0.71,1,1,1.06,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",113,"L",0.46,0.18,-1.86,0.86,0.97,1.1,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",114,"F",0.43,0.16,-3.47,0.85,0.94,1.11,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",115,"C",0.39,0.12,-4.56,0.79,0.92,1.15,121.15,5.52,2.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",116,"I",0.35,0.15,-4.86,0.75,0.9,1.17,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",117,"F",0.32,0.15,-4.86,0.75,0.89,1.17,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",118,"Y",0.29,0.2,-4.07,0.74,0.89,1.22,181.19,5.52,-1.3]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",119,"A",0.28,0.28,-3.46,0.79,0.89,1.14,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",120,"L",0.28,0.23,-3.46,0.79,0.91,1.14,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",121,"V",0.29,0.23,-1.84,0.92,0.92,1.14,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",122,"G",0.3,0.19,-2.89,0.84,0.94,1.15,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",123,"I",0.3,0.19,-4.5,0.83,0.95,1.15,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",124,"P",0.31,0.26,-2.37,0.97,0.95,1.1,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",125,"L",0.32,0.18,-2.99,0.97,0.94,1.07,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",126,"F",0.33,0.22,-5.11,0.83,0.93,1.12,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",127,"G",0.34,0.12,-5.29,0.85,0.92,1.13,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",128,"I",0.35,0.14,-5.29,0.72,0.92,1.13,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",129,"L",0.36,0.16,-3.16,0.86,0.92,1.08,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",130,"L",0.38,0.12,-2.37,0.85,0.93,1.12,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",131,"A",0.4,0.17,-2.37,0.85,0.94,1.12,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",132,"G",0.44,0.35,0.2,0.99,0.96,1.08,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",133,"V",0.46,0.82,2.11,1.04,0.98,1.03,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",134,"G",0.48,0.67,2.11,1.04,1,1.03,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",135,"D",0.5,0.67,2.63,1.17,1.01,1,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",136,"R",0.52,1.21,2.74,1.15,1.03,1.02,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",137,"L",0.54,1.64,4.2,1.28,1.04,0.97,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",138,"G",0.55,0.81,2.07,1.14,1.05,1.02,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",139,"S",0.56,0.81,1.24,1.07,1.05,1.02,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",140,"S",0.56,1.34,0.94,1.07,1.03,1.05,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",141,"L",0.55,1.34,3.07,1.21,1,1,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",142,"R",0.54,0.7,1.11,1.05,0.97,1.04,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",143,"H",0.55,0.52,1,1.07,0.96,1.02,155.16,6.74,-3.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",144,"G",0.55,0.85,0.37,1,0.95,1.03,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",145,"I",0.56,0.31,0.54,0.99,0.95,1.02,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",146,"G",0.56,0.39,1.06,0.96,0.94,1.02,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",147,"H",0.57,0.4,1.06,0.92,0.94,1.01,155.16,6.74,-3.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",148,"I",0.59,0.4,-0.9,0.76,0.93,1.05,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",149,"E",0.59,0.35,-1.07,0.78,0.92,1.04,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",150,"A",0.6,0.21,-3.2,0.64,0.92,1.1,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",151,"I",0.62,0.6,-2.69,0.65,0.93,1.07,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",152,"F",0.63,0.36,-2.97,0.72,0.94,1.03,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",153,"L",0.64,0.49,-3.79,0.75,0.95,1.07,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",154,"K",0.64,0.52,-4.61,0.73,0.95,1.11,146.19,8.75,-3.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",155,"W",0.64,0.93,-3.17,0.88,0.96,1.1,204.23,5.52,-0.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",156,"H",0.64,1.74,-1.56,1.01,0.96,1.1,155.16,6.74,-3.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",157,"V",0.64,1.51,0.87,1.03,0.98,1.04,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",158,"P",0.65,1.18,-1.26,0.97,1,1.09,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",159,"P",0.67,0.64,-0.36,0.9,1.01,1.16,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",160,"E",0.65,1.7,-0.06,0.9,1,1.12,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",161,"L",0.65,0.82,-0.06,0.9,0.98,1.12,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",162,"V",0.63,0.44,-1.67,0.77,0.95,1.15,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",163,"R",0.62,0.34,-1.04,0.76,0.94,1.14,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",164,"V",0.6,0.41,-1.86,0.75,0.93,1.17,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",165,"L",0.58,0.55,-1.14,0.75,0.93,1.11,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",166,"S",0.56,0.23,-1.93,0.76,0.92,1.09,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",167,"A",0.55,0.27,-3.84,0.71,0.91,1.13,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",168,"M",0.52,0.27,-4.63,0.72,0.9,1.11,149.21,5.28,1.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",169,"L",0.53,0.17,-4.63,0.72,0.9,1.11,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",170,"F",0.53,0.12,-6.7,0.59,0.9,1.13,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",171,"L",0.53,0.12,-6.19,0.71,0.91,1.1,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",172,"L",0.55,0.07,-5.39,0.8,0.91,1.18,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",173,"I",0.56,0.07,-5.39,0.8,0.91,1.18,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",174,"G",0.56,0.07,-5.39,0.8,0.91,1.21,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",175,"C",0.55,0.07,-5.39,0.8,0.91,1.18,121.15,5.52,2.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",176,"L",0.52,0.08,-4.6,0.79,0.91,1.2,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",177,"L",0.49,0.07,-4.77,0.8,0.92,1.22,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",178,"F",0.45,0.18,-4.84,0.72,0.93,1.22,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",179,"V",0.43,0.33,-4.74,0.76,0.95,1.17,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",180,"L",0.41,0.58,-2.69,0.82,0.98,1.12,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",181,"T",0.39,0.58,-2.69,0.82,1,1.1,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",182,"P",0.39,0.58,-1.9,0.8,1.01,1.14,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",183,"T",0.39,0.61,-2.69,0.82,0.99,1.1,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",184,"F",0.41,0.23,-1.17,0.9,0.97,1.12,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",185,"V",0.44,0.23,-2.19,0.93,0.94,1.16,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",186,"F",0.47,0.16,-3.09,0.8,0.91,1.12,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",187,"C",0.5,0.32,-2.71,0.77,0.9,1.12,121.15,5.52,2.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",188,"Y",0.52,0.71,0.03,0.89,0.91,1.08,181.19,5.52,-1.3]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",189,"M",0.54,0.87,-0.87,0.96,0.93,1.01,149.21,5.28,1.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",190,"E",0.54,2.16,1.37,1.07,0.97,1,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",191,"D",0.53,2.76,1.99,1.05,1,0.93,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",192,"W",0.53,2.3,0.94,0.97,1.01,0.95,204.23,5.52,-0.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",193,"S",0.51,2.3,2.66,0.99,1.02,0.95,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",194,"K",0.48,1.39,1.84,0.98,1.01,0.98,146.19,8.75,-3.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",195,"L",0.45,0.93,-0.73,0.84,0.98,1.02,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",196,"E",0.41,1.08,0.43,0.86,0.95,1.06,147.13,4,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",197,"A",0.37,0.47,-1.81,0.74,0.93,1.07,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",198,"I",0.34,0.42,-3.16,0.67,0.9,1.14,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",199,"Y",0.3,0.17,-2.99,0.65,0.89,1.12,181.19,5.52,-1.3]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",200,"F",0.28,0.13,-4.63,0.62,0.89,1.2,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",201,"V",0.25,0.26,-4.19,0.66,0.9,1.18,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",202,"I",0.26,0.14,-4.36,0.68,0.91,1.19,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",203,"V",0.26,0.23,-3.34,0.65,0.93,1.15,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",204,"T",0.27,0.44,-1.29,0.71,0.95,1.13,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",205,"L",0.29,0.47,-1.29,0.71,0.98,1.13,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",206,"T",0.32,0.62,0.67,0.86,1,1.09,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",207,"T",0.36,0.37,-0.11,0.88,1,1.05,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",208,"V",0.39,0.45,-0.04,0.96,0.99,1.04,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",209,"G",0.42,0.52,2.7,1.09,0.98,0.99,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",210,"F",0.45,0.56,1.69,1.11,0.98,1.02,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",211,"G",0.46,0.56,0.41,1.05,0.99,1.09,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",212,"D",0.48,0.58,1.24,1.07,0.99,1.04,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",213,"Y",0.49,0.66,1.24,1.07,0.97,1.04,181.19,5.52,-1.3]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",214,"V",0.51,0.67,2.86,1.08,0.96,1.04,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",215,"A",0.54,0.67,3.47,1.06,0.96,1.04,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",216,"G",0.56,0.66,2.34,1.07,0.98,1.07,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",217,"A",0.58,1.75,3.21,1.04,1.01,1.03,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",218,"D",0.59,3,4.6,1.11,1.04,0.97,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",219,"P",0.6,5.06,5.73,1.23,1.06,0.95,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",220,"R",0.63,6.71,5.84,1.21,1.08,0.97,174.2,9.75,-4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",221,"Q",0.64,6.21,5.84,1.33,1.09,0.97,146.15,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",222,"D",0.64,4.06,4.71,1.22,1.09,0.99,133.1,3.8,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",223,"S",0.63,3.25,4.14,1.16,1.08,1.01,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",224,"P",0.6,3.25,4.4,1.17,1.05,1.03,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",225,"A",0.57,3.01,3.84,1.24,1.02,1.04,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",226,"Y",0.54,1.85,1.1,1.12,1.01,1.09,181.19,5.52,-1.3]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",227,"Q",0.51,0.89,-0.36,0.99,1,1.14,146.15,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",228,"P",0.48,0.92,-2.09,0.91,0.98,1.12,115.13,5.96,-1.6]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",229,"L",0.44,0.51,-3.7,0.9,0.96,1.12,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",230,"V",0.4,0.31,-4.86,0.87,0.92,1.08,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",231,"W",0.37,0.14,-6.86,0.8,0.89,1.1,204.23,5.52,-0.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",232,"F",0.34,0.14,-8.47,0.67,0.87,1.13,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",233,"W",0.31,0.16,-8.47,0.67,0.87,1.13,204.23,5.52,-0.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",234,"I",0.29,0.15,-7.13,0.82,0.88,1.06,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",235,"L",0.29,0.14,-7.01,0.77,0.91,1.11,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",236,"L",0.3,0.13,-5.4,0.77,0.92,1.1,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",237,"G",0.29,0.3,-4.24,0.8,0.92,1.14,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",238,"L",0.28,0.32,-4.41,0.82,0.92,1.13,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",239,"A",0.29,0.39,-2.8,0.83,0.91,1.11,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",240,"Y",0.29,0.52,-0.56,0.95,0.9,1.07,181.19,5.52,-1.3]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",241,"F",0.3,0.47,-1.9,0.8,0.91,1.15,165.19,5.52,2.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",242,"A",0.33,0.38,-1.9,0.8,0.92,1.15,89.09,5.57,1.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",243,"S",0.35,0.35,-1.46,0.84,0.93,1.12,105.09,5.24,-0.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",244,"V",0.35,0.59,-0.44,0.81,0.96,1.09,117.15,5.49,4.2]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",245,"L",0.34,0.41,-0.27,0.8,0.98,1.1,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",246,"T",0.36,0.3,0.24,0.92,1,1.07,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",247,"T",0.39,0.66,0.31,0.94,1.02,1.04,119.12,5.19,-0.7]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",248,"I",0.4,0.84,-0.59,1.01,1.02,0.97,131.17,5.52,4.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",249,"G",0.41,0.48,-0.59,1.01,1.01,0.97,75.07,5.52,-0.4]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",250,"N",0.37,0.65,-0.73,1.01,0,0.96,132.12,5.52,-3.5]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",251,"W",0.33,0,0,0,0,0,204.23,5.52,-0.9]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",252,"L",0.28,0,0,0,0,0,131.17,5.52,3.8]
["4WFF_B Chain B of Human TRAAK K+ channel in a K+ bound nonconductive conformation",253,"R",0.24,0,0,0,0,0,174.2,9.75,-4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",1,"C",0.24,0,0,0,0,0,121.15,5.52,2.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",2,"D",0.29,0,0,0,0,0,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",3,"A",0.34,0.12,0,0,0,0,89.09,5.57,1.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",4,"F",0.4,0.32,1.64,0.99,0.95,1.09,165.19,5.52,2.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",5,"V",0.45,0.2,0.01,0.96,0.96,1.01,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",6,"G",0.47,0.4,-0.6,0.89,0.99,1.02,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",7,"T",0.49,0.38,-2.21,0.88,1,1.05,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",8,"W",0.5,0.38,-1.43,0.87,0.99,1.09,204.23,5.52,-0.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",9,"K",0.52,0.52,0.03,1,1,1.04,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",10,"L",0.53,0.48,0.14,0.98,1,1.06,131.17,5.52,3.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",11,"V",0.55,0.79,0.51,0.95,1.01,1.05,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",12,"S",0.56,0.64,2.94,1.04,1.04,1.03,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",13,"S",0.57,0.67,0.81,0.98,1.05,1.05,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",14,"E",0.58,1.51,3.56,1.1,1.05,1,147.13,4,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",15,"N",0.58,1.88,5.51,1.24,1.05,0.92,132.12,5.52,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",16,"F",0.55,2.2,4.31,1.2,1.03,0.95,165.19,5.52,2.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",17,"D",0.55,1.26,2.79,1.08,1.02,0.92,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",18,"D",0.55,1.56,2.49,1.12,1.01,0.93,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",19,"Y",0.54,3.13,2.6,1,0.99,0.94,181.19,5.52,-1.3]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",20,"M",0.53,1.39,3.39,0.99,0.99,0.98,149.21,5.28,1.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",21,"K",0.53,0.82,2.77,1,0.99,0.98,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",22,"E",0.52,0.39,0.81,0.86,0.99,1.06,147.13,4,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",23,"V",0.53,0.39,1.9,0.92,0.98,1.02,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",24,"G",0.54,0.17,1.19,0.92,0.97,1.06,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",25,"V",0.55,0.1,0.67,0.87,0.95,1.07,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",26,"G",0.55,0.19,0.3,0.91,0.95,1.08,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",27,"F",0.54,0.38,1.43,0.97,0.96,1.01,165.19,5.52,2.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",28,"A",0.54,1.02,1.43,0.89,0.98,1.02,89.09,5.57,1.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",29,"T",0.52,0.77,1.43,0.89,1,1.02,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",30,"R",0.53,0.89,0.91,0.76,1.01,1.04,174.2,9.75,-4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",31,"K",0.52,0.88,3.04,0.9,1.01,1.01,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",32,"V",0.51,0.6,2.14,0.89,0.98,0.98,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",33,"A",0.51,0.31,1.7,0.85,0.95,1,89.09,5.57,1.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",34,"G",0.51,0.31,1.91,0.86,0.94,1.01,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",35,"M",0.5,0.65,1.4,0.93,0.94,1.03,149.21,5.28,1.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",36,"A",0.48,1.03,2.93,1.08,0.97,0.94,89.09,5.57,1.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",37,"K",0.47,1.03,2.03,1.07,0.99,0.91,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",38,"P",0.46,0.73,0.07,0.92,0.99,0.95,115.13,5.96,-1.6]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",39,"N",0.45,0.5,-0.47,0.9,0.97,0.99,132.12,5.52,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",40,"M",0.45,0.34,0.16,1.01,0.94,0.99,149.21,5.28,1.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",41,"I",0.45,0.16,-1.19,0.94,0.92,1.05,131.17,5.52,4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",42,"I",0.45,0.16,-0.49,0.94,0.92,1.01,131.17,5.52,4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",43,"S",0.46,0.16,-0.67,0.94,0.94,1.02,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",44,"V",0.47,0.39,1.36,1.06,0.98,1.03,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",45,"N",0.47,0.46,1.19,1.08,1.02,1.04,132.12,5.52,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",46,"G",0.47,0.25,1.8,1.09,1.04,1.08,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",47,"D",0.47,0.49,1.61,1.02,1.03,1.06,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",48,"L",0.47,0.21,1,1.01,1,1.03,131.17,5.52,3.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",49,"V",0.46,0.42,0.6,0.93,0.98,1.04,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",50,"T",0.46,0.34,0.71,0.91,0.98,1.06,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",51,"I",0.45,0.71,0.4,0.81,1.01,1.06,131.17,5.52,4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",52,"R",0.45,1.29,2.64,0.93,1.05,1.03,174.2,9.75,-4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",53,"S",0.45,1.29,3.91,0.99,1.09,0.96,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",54,"E",0.47,1.59,1.86,0.94,1.09,0.99,147.13,4,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",55,"S",0.49,1.62,3.81,1.02,1.09,0.95,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",56,"T",0.5,1.95,4.21,1.1,1.07,0.94,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",57,"F",0.51,1.62,4.03,1.04,1.05,0.93,165.19,5.52,2.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",58,"K",0.51,2.1,4.03,1.04,1.06,0.93,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",59,"N",0.5,1.02,1.96,0.9,1.06,0.95,132.12,5.52,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",60,"T",0.49,1.58,2.14,0.97,1.05,0.96,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",61,"E",0.48,0.68,2.14,0.97,1.03,0.96,147.13,4,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",62,"I",0.47,0.85,2.14,0.97,1,0.96,131.17,5.52,4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",63,"S",0.46,0.49,-0.17,0.83,0.98,1.03,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",64,"F",0.45,0.28,-0.1,0.91,0.97,1.02,165.19,5.52,2.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",65,"K",0.46,0.29,-1.74,0.88,0.97,1.1,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",66,"L",0.46,0.38,0.51,0.92,0.97,1.06,131.17,5.52,3.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",67,"G",0.47,0.38,-1.73,0.8,0.96,1.07,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",68,"V",0.49,0.32,1.01,0.92,0.96,1.04,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",69,"E",0.52,0.67,1.31,0.88,0.97,1.02,147.13,4,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",70,"F",0.53,0.47,1.49,0.87,0.98,1.01,165.19,5.52,2.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",71,"D",0.54,0.92,1.41,0.78,1,1.01,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",72,"E",0.56,0.53,2.24,0.8,1.01,0.97,147.13,4,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",73,"I",0.57,1.03,2.56,0.91,1.01,0.97,131.17,5.52,4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",74,"T",0.58,1.03,5.3,1.03,1.01,0.94,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",75,"A",0.59,1.17,4.47,0.96,1.02,0.94,89.09,5.57,1.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",76,"D",0.58,3.33,4.17,1,1.04,0.95,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",77,"D",0.56,1.71,4.79,1,1.04,0.98,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",78,"R",0.54,3.39,4.86,1.01,1.05,0.99,174.2,9.75,-4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",79,"K",0.52,2.72,5.49,1.12,1.05,0.98,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",80,"V",0.49,1.14,2.91,0.98,1.03,1.02,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",81,"K",0.48,0.41,0.34,0.83,1.02,1.06,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",82,"S",0.46,0.29,0.49,0.84,0.99,1.07,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",83,"I",0.43,0.33,-1.64,0.78,0.96,1.11,131.17,5.52,4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",84,"I",0.42,0.27,0.31,0.91,0.95,1.04,131.17,5.52,4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",85,"T",0.43,0.2,0.31,0.99,0.97,1.03,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",86,"L",0.43,0.28,0.2,1.01,1,1.01,131.17,5.52,3.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",87,"D",0.43,0.41,1.64,1.04,1.03,1,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",88,"G",0.44,0.23,1.47,1.05,1.04,1.01,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",89,"G",0.46,0.21,0.2,0.99,1.02,1.08,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",90,"A",0.46,0.22,2.37,1.04,0.99,1.05,89.09,5.57,1.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",91,"L",0.47,0.16,0.41,0.91,0.96,1.12,131.17,5.52,3.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",92,"V",0.49,0.29,0.46,0.82,0.94,1.14,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",93,"Q",0.5,0.57,0.46,0.75,0.95,1.15,146.15,5.52,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",94,"V",0.52,0.73,-1.27,0.79,0.97,1.12,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",95,"Q",0.53,1.63,1.47,0.91,1,1.07,146.15,5.52,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",96,"K",0.54,0.93,2.81,1.06,1.02,1,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",97,"W",0.55,2.51,2.77,1.07,1.04,0.98,204.23,5.52,-0.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",98,"D",0.55,1.94,4.23,1.2,1.07,0.93,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",99,"G",0.56,1.4,4.11,1.2,1.09,0.92,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",100,"K",0.55,1.93,4.04,1.19,1.1,0.91,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",101,"S",0.55,0.81,4.33,1.12,1.1,0.95,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",102,"T",0.54,1.63,3.71,1.06,1.09,0.96,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",103,"T",0.53,1.6,3.5,0.97,1.07,0.96,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",104,"I",0.52,2.39,3.5,0.97,1.06,0.96,131.17,5.52,4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",105,"K",0.52,3.24,3.17,0.9,1.05,0.94,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",106,"R",0.51,3.75,3.86,0.97,1.05,0.93,174.2,9.75,-4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",107,"K",0.51,5.29,3.93,1.06,1.06,0.93,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",108,"R",0.51,4.42,6.5,1.2,1.06,0.89,174.2,9.75,-4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",109,"D",0.5,4.51,6.5,1.2,1.07,0.89,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",110,"G",0.49,1.86,4.59,1.15,1.07,0.94,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",111,"D",0.47,0.71,3.24,1.08,1.05,1.01,133.1,3.8,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",112,"K",0.46,0.31,2.11,1.01,1.02,1.08,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",113,"L",0.44,0.55,1.8,0.91,0.99,1.08,131.17,5.52,3.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",114,"V",0.43,0.18,1.19,0.86,0.95,1.15,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",115,"V",0.43,0.07,-0.77,0.72,0.93,1.23,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",116,"E",0.43,0.08,-2.19,0.66,0.91,1.21,147.13,4,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",117,"C",0.42,0.21,-0.06,0.72,0.91,1.17,121.15,5.52,2.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",118,"V",0.41,0.28,1.29,0.87,0.93,1.09,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",119,"M",0.42,0.12,1.29,0.87,0.95,1.09,149.21,5.28,1.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",120,"K",0.42,0.33,0.91,0.9,0.98,1.1,146.19,8.75,-3.9]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",121,"G",0.43,0.59,1.64,0.94,1.02,1.05,75.07,5.52,-0.4]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",122,"V",0.45,0.86,2.91,1,1.04,0.98,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",123,"T",0.44,0.84,4.11,1.05,1.06,0.98,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",124,"S",0.44,0.63,2.77,0.98,1.06,1.05,105.09,5.24,-0.8]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",125,"T",0.44,1.33,1.69,0.92,1.05,1.09,119.12,5.19,-0.7]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",126,"R",0.45,1.59,3.33,0.95,1.02,1.01,174.2,9.75,-4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",127,"V",0.45,2.33,3.19,0.95,1,1.01,117.15,5.49,4.2]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",128,"Y",0.4,1.63,2.56,0.84,0,1.02,181.19,5.52,-1.3]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",129,"E",0.35,0,0,0,0,0,147.13,4,-3.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",130,"R",0.31,0,0,0,0,0,174.2,9.75,-4.5]
["5C0N_A Chain A of Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.",131,"A",0.25,0,0,0,0,0,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",1,"L",0.26,0,0,0,0,0,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",2,"G",0.31,0,0,0,0,0,75.07,5.52,-0.4]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",3,"S",0.37,1.28,0,0,0,0,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",4,"R",0.43,1.28,1.06,1,1.06,1.01,174.2,9.75,-4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",5,"R",0.48,1.28,1.77,1.01,1.03,0.95,174.2,9.75,-4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",6,"T",0.46,0.79,-0.36,0.87,1,1,119.12,5.19,-0.7]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",7,"L",0.47,0.33,-2.6,0.75,0.96,1.03,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",8,"M",0.47,0.17,-2.9,0.71,0.92,1.06,149.21,5.28,1.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",9,"L",0.44,0.21,-2.64,0.71,0.91,1.08,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",10,"L",0.46,0.25,-3.99,0.66,0.91,1.07,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",11,"A",0.47,0.49,-2.07,0.71,0.92,1.01,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",12,"Q",0.48,1.18,-0.66,0.77,0.94,1.03,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",13,"M",0.49,1.01,-0.49,0.75,0.97,1.02,149.21,5.28,1.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",14,"R",0.51,1.33,1.76,0.87,0.99,0.98,174.2,9.75,-4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",15,"K",0.54,0.64,0.14,0.86,1,1.01,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",16,"I",0.55,0.56,-2.03,0.81,0.99,1.02,131.17,5.52,4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",17,"S",0.55,0.38,-0.5,0.93,0.97,1.05,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",18,"L",0.59,0.1,-0.9,0.96,0.95,1.12,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",19,"F",0.58,0.12,-3.03,0.9,0.93,1.17,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",20,"S",0.57,0.18,-1.07,0.98,0.93,1.14,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",21,"C",0.57,0.36,-0.57,0.98,0.95,1.12,121.15,5.52,2.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",22,"L",0.58,0.82,1.34,1.03,0.97,1.06,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",23,"K",0.58,0.83,2.96,1.08,1,1.06,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",24,"D",0.56,2.59,3.46,1.09,1.01,1.04,133.1,3.8,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",25,"R",0.57,2.72,1.94,1,1,1,174.2,9.75,-4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",26,"H",0.57,1.35,4.07,1.14,0.98,0.94,155.16,6.74,-3.2]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",27,"D",0.56,0.7,1.94,1.08,0.96,0.97,133.1,3.8,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",28,"F",0.55,0.55,0.81,1.09,0.95,0.99,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",29,"G",0.55,0.7,1.07,1.1,0.97,1.02,75.07,5.52,-0.4]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",30,"F",0.54,0.73,1.89,1.07,1,0.98,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",31,"P",0.53,1.46,1.57,0.96,1.04,0.98,115.13,5.96,-1.6]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",32,"Q",0.54,1.27,1.57,0.96,1.06,0.98,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",33,"E",0.55,1.46,1.57,0.96,1.06,0.98,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",34,"E",0.56,1.52,3.89,1.1,1.05,0.93,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",35,"F",0.58,1.52,4.44,1.02,1.04,0.92,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",36,"G",0.6,0.76,2.27,0.97,1.03,0.94,75.07,5.52,-0.4]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",37,"N",0.6,0.76,2.01,1,1.03,0.96,132.12,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",38,"Q",0.61,1.75,1.71,1.04,1.03,0.97,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",39,"F",0.61,1.79,3.33,1.05,1.02,0.97,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",40,"Q",0.6,1.92,3.63,0.93,1.03,0.96,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",41,"K",0.57,1.6,3.37,0.85,1.03,0.98,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",42,"A",0.55,1.3,1.37,0.77,1.04,1,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",43,"E",0.51,1.16,2.99,0.91,1.03,1,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",44,"T",0.46,0.43,1.6,0.84,1.02,1.05,119.12,5.19,-0.7]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",45,"I",0.44,0.35,-0.53,0.78,0.99,1.1,131.17,5.52,4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",46,"P",0.41,0.28,-0.53,0.82,0.97,1.1,115.13,5.96,-1.6]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",47,"V",0.38,0.33,-0.53,0.82,0.95,1.1,117.15,5.49,4.2]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",48,"L",0.35,0.47,-1.87,0.77,0.93,1.09,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",49,"H",0.34,0.21,-1.87,0.77,0.92,1.09,155.16,6.74,-3.2]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",50,"E",0.35,0.49,-1.31,0.69,0.92,1.08,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",51,"M",0.34,1.04,0.07,0.76,0.93,1.03,149.21,5.28,1.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",52,"I",0.36,0.53,0.24,0.74,0.94,1.02,131.17,5.52,4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",53,"Q",0.39,0.27,-1.37,0.69,0.95,1.01,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",54,"Q",0.38,0.43,-1.49,0.81,0.95,1,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",55,"I",0.38,0.51,-2.2,0.81,0.95,1.06,131.17,5.52,4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",56,"F",0.41,0.26,-2.37,0.83,0.94,1.06,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",57,"N",0.44,0.2,-2.3,0.89,0.94,1.06,132.12,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",58,"L",0.46,0.41,-2.41,0.89,0.95,1.04,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",59,"F",0.49,0.94,-0.46,0.96,0.98,1.01,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",60,"S",0.54,0.98,2.29,1.09,1.01,0.98,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",61,"T",0.56,1.59,2.21,1.07,1.05,1.01,119.12,5.19,-0.7]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",62,"K",0.58,2.46,4.46,1.19,1.07,0.98,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",63,"D",0.6,1.85,6.07,1.2,1.07,0.97,133.1,3.8,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",64,"S",0.62,1.3,5.44,1.09,1.06,0.98,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",65,"S",0.62,0.68,3.27,1.09,1.02,0.98,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",66,"A",0.63,0.68,3.89,1.15,0.99,0.97,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",67,"A",0.62,0.88,3.57,1.05,0.98,0.97,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",68,"W",0.59,0.95,3.39,0.98,0.99,0.95,204.23,5.52,-0.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",69,"D",0.56,0.77,1.14,0.86,1.01,0.99,133.1,3.8,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",70,"E",0.53,0.63,-0.47,0.85,1.03,1.01,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",71,"T",0.52,1,0.66,0.97,1.03,0.98,119.12,5.19,-0.7]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",72,"L",0.48,1.2,2.9,0.97,1.03,0.99,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",73,"L",0.48,0.6,0.16,0.85,1.02,1.02,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",74,"D",0.47,0.65,-1.23,0.91,1.01,1.07,133.1,3.8,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",75,"K",0.45,1.14,-1.23,0.91,1.01,1.07,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",76,"F",0.42,2.4,1.2,0.93,1,1.01,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",77,"Y",0.43,1.18,1.2,0.93,0.99,1.01,181.19,5.52,-1.3]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",78,"T",0.44,0.93,-0.5,0.88,0.99,1.05,119.12,5.19,-0.7]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",79,"E",0.44,1.85,-0.46,0.88,0.99,1.06,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",80,"L",0.43,2.05,1.71,0.93,0.99,1.05,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",81,"Y",0.46,1.17,0.67,0.85,0.99,1.06,181.19,5.52,-1.3]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",82,"Q",0.47,1.09,0.93,0.94,0.99,1.05,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",83,"Q",0.46,2.2,1.24,1.04,1,1.05,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",84,"L",0.48,1.16,1.24,1.04,1.01,1.05,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",85,"N",0.51,1.16,2.63,0.99,1.01,1,132.12,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",86,"D",0.48,0.68,2.07,0.94,1,1.01,133.1,3.8,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",87,"L",0.48,0.44,1.41,0.97,0.98,1.07,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",88,"E",0.48,0.2,2.2,0.96,0.96,1.09,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",89,"A",0.5,0.09,0.06,0.8,0.94,1.14,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",90,"C",0.5,0.18,-0.51,0.73,0.93,1.16,121.15,5.52,2.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",91,"V",0.51,0.1,1.61,0.87,0.94,1.11,117.15,5.49,4.2]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",92,"I",0.54,0.1,-0.1,0.85,0.95,1.1,131.17,5.52,4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",93,"Q",0.53,0.37,0.41,0.9,0.98,1.08,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",94,"G",0.54,0.87,1.33,0.84,1,1,75.07,5.52,-0.4]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",95,"M",0.56,2.08,3.29,0.97,1.02,0.93,149.21,5.28,1.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",96,"K",0.57,1.61,5.36,1.11,1.04,0.91,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",97,"E",0.57,1.14,3.36,1.04,1.04,0.93,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",98,"D",0.56,0.95,1.23,0.9,1.02,0.98,133.1,3.8,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",99,"S",0.53,0.48,2.13,0.91,1,1.02,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",100,"I",0.52,0.21,0.79,0.84,0.96,1.08,131.17,5.52,4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",101,"L",0.53,0.24,0.27,0.87,0.94,1.09,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",102,"A",0.51,0.36,-0.34,0.8,0.94,1.09,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",103,"V",0.49,0.8,-1.54,0.76,0.96,1.12,117.15,5.49,4.2]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",104,"R",0.48,0.84,-1.71,0.78,0.98,1.11,174.2,9.75,-4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",105,"K",0.48,1.45,0.46,0.83,0.99,1.07,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",106,"Y",0.46,3.82,0.76,0.88,0.99,1.05,181.19,5.52,-1.3]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",107,"F",0.46,1.37,0.14,0.87,0.99,1.01,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",108,"Q",0.49,0.99,0.29,0.87,0.99,1.02,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",109,"R",0.48,0.52,-1.84,0.81,0.99,1.06,174.2,9.75,-4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",110,"I",0.44,0.94,-1.84,0.81,0.98,1.06,131.17,5.52,4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",111,"T",0.44,0.45,-1.84,0.81,0.96,1.09,119.12,5.19,-0.7]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",112,"L",0.47,0.46,-1.89,0.82,0.95,1.08,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",113,"Y",0.48,1.13,-1.37,0.79,0.95,1.07,181.19,5.52,-1.3]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",114,"L",0.47,1.56,0.59,0.86,0.98,1.04,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",115,"K",0.5,3.79,0.66,0.87,1.02,1.04,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",116,"E",0.49,3.79,1.7,0.95,1.05,1.03,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",117,"K",0.48,6.16,2.9,0.99,1.06,1.01,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",118,"K",0.48,4.76,4.51,1.12,1.06,0.98,146.19,8.75,-3.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",119,"Y",0.49,1.47,3.9,1.15,1.04,1.05,181.19,5.52,-1.3]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",120,"S",0.48,0.74,3.09,1.14,1.01,1.08,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",121,"P",0.46,0.39,0.84,1.13,0.99,1.08,115.13,5.96,-1.6]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",122,"C",0.45,0.43,1.14,1.09,0.95,1.07,121.15,5.52,2.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",123,"A",0.41,0.24,0.89,1,0.94,1.1,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",124,"W",0.4,0.11,-0.57,0.87,0.92,1.15,204.23,5.52,-0.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",125,"E",0.39,0.42,-0.27,0.79,0.92,1.12,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",126,"V",0.38,0.42,-0.17,0.71,0.93,1.07,117.15,5.49,4.2]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",127,"V",0.36,0.69,0.64,0.72,0.94,1.04,117.15,5.49,4.2]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",128,"R",0.39,0.28,0.93,0.65,0.94,1.08,174.2,9.75,-4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",129,"A",0.4,0.37,-0.79,0.63,0.94,1.08,89.09,5.57,1.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",130,"E",0.39,0.99,0.34,0.7,0.94,1,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",131,"I",0.37,0.67,1.8,0.83,0.94,0.95,131.17,5.52,4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",132,"M",0.4,0.58,-0.11,0.78,0.95,0.98,149.21,5.28,1.9]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",133,"R",0.41,0.45,0.51,0.89,0.96,0.97,174.2,9.75,-4.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",134,"S",0.41,0.53,-1.91,0.87,0.97,1.03,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",135,"F",0.42,0.71,0.16,1,0.97,1.01,165.19,5.52,2.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",136,"S",0.45,0.52,1.5,1.06,0.98,1.02,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",137,"L",0.43,0.63,1.9,1.14,0.99,1.01,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",138,"S",0.43,0.6,-0.34,1.02,1,1.04,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",139,"T",0.45,0.78,1.83,1.08,1.02,1.03,119.12,5.19,-0.7]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",140,"N",0.47,1.63,2.01,0.98,1.02,1.01,132.12,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",141,"L",0.45,1.63,4.26,1.1,1.02,0.97,131.17,5.52,3.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",142,"Q",0.39,0.93,2.01,0.98,0,1.01,146.15,5.52,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",143,"E",0.36,0,0,0,0,0,147.13,4,-3.5]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",144,"S",0.29,0,0,0,0,0,105.09,5.24,-0.8]
["4Z5R_A Chain A of Rontalizumab Fab bound to Interferon-a2",145,"L",0.24,0,0,0,0,0,131.17,5.52,3.8]